Plasmodium falciparum drug resistance in Angola

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Fançony, Cláudia ^a   Brito, Miguel ^a,b   Gil, Jose Pedro ^c  

^a Health Research Center of Angola (CISA Translated)   (Angola)

^b INSTITUTO POLITÉCNICO DE LISBOA   (Portugal)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Drug efficacy and molecular markers; Malaria

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; CARRIER PROTEIN; CHLOROQUINE; CHLOROQUINE RESISTANCE TRANSPORTER; DIHYDROARTEMISININ PLUS PIPERAQUINE; MOLECULAR MARKER; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT;

ALLELE; ANGOLA; ANTIMALARIAL DRUG RESISTANCE; CLINICAL TRIAL (TOPIC); COMBINATION CHEMOTHERAPY; DRUG EFFICACY; HEALTH PROGRAM; HUMAN; IN VIVO STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MONOTHERAPY; NONHUMAN; PFCRT GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; PREVALENCE; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; REVIEW; TREATMENT OUTCOME; DRUG EFFECTS; DRUG RESISTANCE; MALARIA, FALCIPARUM; PHYSIOLOGY;

ANGOLA; ANTIMALARIALS; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

EID: 84959482877     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1122-z     Document Type: Review

References (73)

1. WHO. World malaria report 2014. Geneva: World Health Organization; 2014.
2. Rowe AK, de Leon GF, Mihigo J, Santelli AC, Miller NP, Van-Dunem P. Quality of malaria case management at outpatient health facilities in Angola. Malar J. 2009;8:275.
3. Ministério da Saúde da República de Angola. Plano Nacional de Desenvolvimento Sanitário 2012-2025. 2014; 1: 119.
4. http://www.malariaeliminationgroup.org/resources/regional-and-cross-border-initiatives-elimination/elimination-eight-e8. 12 Nov 2015.
5. Webb JLA Jr. The long struggle against malaria in tropical Africa. Cambridge University Press; 2014.
6. Rodrigues Coura J. Development of malaria hematozoa resistant to quinine. By Arthur Neiva, 1910. Mem Inst Oswaldo Cruz. 1987;82:303-9.
7. da Silva AF, Benchimol JL. Malaria and quinine resistance: A medical and scientific issue between Brazil and Germany (1907-19). Med Hist. 2014;58:1-26.
8. Cambournac FJ, Gandara AF, Pena AJ. Preventive effects of daraprim in a native community (Catholic Mission of Huambo, Angola) (in Portuguese). An Inst Med Trop (Lisb). 1955;12(3):341-57.
9. Bruce-Chwatt LJ. Malaria eradication in Portugal. Trans R Soc Trop Med Hyg. 1977;71:232-40.
10. Mbomo SA, Ochrymowicz J. The possible presence in Cameroon of chloroquine resistant strains of Plasmodium falciparum (in French). Bull World Health Organ. 1970;42:168-70.
11. Bruce-Chwatt LJ. Resistance of P. falciparum to chloroquine in Africa: True or false? Trans R Soc Trop Med Hyg. 1970;64:776-84.
12. Bruce-Chwatt LJ, Roberts JM. Chloroquine-resistant malaria? BMJ. 1972;2:108-9.
13. Pillay N, Bhoola RL. Probable chloroquine-resistant Plasmodium falciparum malaria from Mozambique A case report. S Afr Med J. 1975;49:1443-4.
14. Campbell CC, Chin W, Collins WE, Teutsch SM, Moss DM. Chloroquine-resistant Plasmodium falciparum from East Africa: Cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. Lancet. 1979;2:1151-4.
15. Ariey F, Fandeur T, Durand R, Randrianarivelojosia M, Jambou R, Legrand E, et al. Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J. 2006;5:34.
16. Olsen VV, Jensen T, Jorgensen M. Chloroquine-resistant Plasmodium falciparum malaria from Angola. Lancet. 1984;1:1462-3.
17. Lindberg J, Sandberg T, Bjorkholm B, Bjorkman A. Chloroquine and Fansidar resistant malaria acquired in Angola. Lancet. 1985;1:765.
18. Guthmann JP, Cohuet S, Rigutto C, Fortes F, Saraiva N, Kiguli J, et al. High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. Am J Trop Med Hyg. 2006;75(1):143-5.
19. Guthmann JP, Ampuero J, Fortes F, van Overmeir C, Gaboulaud V, Tobback S, et al. Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola. Trans R Soc Trop Med Hyg. 2005;99(7):485-92.
20. Martensson A, Stromberg J, Sisowath C, Msellem MI, Gil JP, Montgomery SM, et al. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis. 2005;41:1079-86.
21. Martensson A, Ngasala B, Ursing J, Isabel Veiga M, Wiklund L, Membi C, et al. Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania. J Infect Dis. 2007;195:597-601.
22. Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: Parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg. 2014;91:833-43.
23. Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, et al. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uige Provinces, angola. Antimicrob Agents Chemother. 2015;59(1):437-43.
24. Zani B, Gathu M, Donegan S, Olliaro PL, Sinclair D. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev. 2014;1:CD010927.
25. Hamed K, Kuhen K. No robust evidence of lumefantrine resistance. Antimicrob Agents Chemother. 2015;59:5865-6.
26. Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, et al. Reply to "No Robust Evidence of Lumefantrine Resistance". Antimicrob Agents Chemother. 2015;59:5867-8.
27. Ngasala BE, Malmberg M, Carlsson AM, Ferreira PE, Petzold MG, Blessborn D, et al. Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: A randomized trial. Clin Infect Dis. 2011;52:873-82.
28. Malmberg M, Ferreira PE, Tarning J, Ursing J, Ngasala B, Bjorkman A, et al. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms. J Infect Dis. 2013;207:842-7.
29. Kiaco K, Teixeira J, Machado M, do Rosario V, Lopes D. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola. Malar J. 2015;14(1):504.
30. Van Hong N, Amambua-Ngwa A, Tuan NQ, do Cuong D, Giang NT, Van Dung N, et al. Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam. Emerg Infect Dis. 2014;20:1199-202.
31. Ringwald P, Dondorp AM. Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam. Emerg Infect Dis. 2015;21:1264-5.
32. Van Hong N, Amambua-Ngwa A, Tuan NQ, do Cuong D, Giang NT, Van Dung N, et al. Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam. Emerg Infect Dis. 2015;21:1265.
33. WHO. World Malaria Report. Geneva; World Health Organization; 2006.
34. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257-63.
35. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000;6:861-71.
36. Sidhu AB, Verdier-Pinard D, Fidock DA. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science. 2002;298:210-3.
37. Kryger T, Nahorski W, Wojtacha A, Szostakowska B, Pietkiewicz H, Myjak P. Assessment of clinical course and outcome of Plasmodium falciparum malaria in Angola diagnosed by microscopic and molecular methods. Int Marit Health. 2004;55(1-4):75-85.
38. Menegon M, Pearce RJ, Inojosa WO, Pisani V, Abel PM, Matondo A, et al. Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola. Trop Med Int Health. 2009;14(10):1251-7.
39. Figueiredo P, Benchimol C, Lopes D, Bernardino L, do Rosario VE, Varandas L, et al. Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola. Malar J. 2008;7(7):236-50.
40. Gama BE, Pereira-Carvalho GA, Lutucuta Kosi FJ, Almeida de Oliveira NK, Fortes F, Rosenthal PJ, et al. Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene. Malar J. 2010;9(10):174.
41. Vieira PP, Ferreira MU, Alecrim M, Alecrim WD, da Silva LH, Sihuincha MM, et al. Pfcrt Polymorphism and the spread of chloroquine resistance in Plasmodium falciparum populations across the Amazon Basin. J Infect Dis. 2004;190:417-24.
42. Echeverry DF, Holmgren G, Murillo C, Higuita JC, Bjorkman A, Gil JP, et al. Polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine. Am J Trop Med Hyg. 2007;77:1034-8.
43. Alifrangis M, Dalgaard MB, Lusingu JP, Vestergaard LS, Staalsoe T, Jensen AT, et al. Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. J Infect Dis. 2006;193:1738-41.
44. Sa JM, Twu O, Hayton K, Reyes S, Fay MP, Ringwald P, et al. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc Natl Acad Sci USA. 2009;106:18883-9.
45. Beshir K, Sutherland CJ, Merinopoulos I, Durrani N, Leslie T, Rowland M, et al. Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76. Antimicrob Agents Chemother. 2010;54:3714-6.
46. Fancony C, Gamboa D, Sebastiao Y, Hallett R, Sutherland C, Sousa-Figueiredo JC, et al. Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola. Antimicrob Agents Chemother. 2012;56(10):5271-7.
47. Foumane Ngane V, Allico Djaman J, Culeux C, Piette N, Carnevale P, Besnard P, et al. Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola. Malar J. 2015;14(14):113-20.
48. Sa JM, Twu O. Protecting the malaria drug arsenal: Halting the rise and spread of amodiaquine resistance by monitoring the PfCRT SVMNT type. Malar J. 2010;9:374.
49. Sisowath C, Petersen I, Veiga MI, Martensson A, Premji Z, Bjorkman A, et al. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. J Infect Dis. 2009;199:750-7.
50. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, et al. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature. 1990;345:255-8.
51. Holmgren G, Hamrin J, Svard J, Martensson A, Gil JP, Bjorkman A. Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa. Infect Genet Evol. 2007;7:562-9.
52. Sisowath C, Stromberg J, Martensson A, Msellem M, Obondo C, Bjorkman A, et al. In vivo selection of Plasmodium falciparum pfmdr1 86 N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis. 2005;191:1014-7.
53. Sisowath C, Ferreira PE, Bustamante LY, Dahlstrom S, Martensson A, Bjorkman A, et al. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop Med Int Health. 2007;12:736-42.
54. Humphreys GS, Merinopoulos I, Ahmed J, Whitty CJ, Mutabingwa TK, Sutherland CJ, et al. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob Agents Chemother. 2007;51:991-7.
55. Pinheiro L, Franco S, Adagu IS, Rosa R, Rosario VE, Warhurst DC. Presence of the double pfmdr1 mutation 86Tyr and 1246 Tyr in clones of a chloroquine-resistant west African isolate of Plasmodium falciparum (in Portuguese). Acta Med Port. 2003;16(4):229-33.
56. Ursing J, Kofoed PE, Rombo L, Gil JP. No pfmdr1 amplifications in samples from Guinea-Bissau and Liberia collected between 1981 and 2004. J Infect Dis. 2006;194:716-8 (author reply 718-9).
57. Price RN, Uhlemann AC, van Vugt M, Brockman A, Hutagalung R, Nair S, et al. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin Infect Dis. 2006;42:1570-7.
58. Gregson A, Plowe CV. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev. 2005;57:117-45.
59. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002;185:380-8.
60. Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Jahevitra M, Rabearimanana S, Radrianjafy R, et al. Plasmodium falciparum drug resistance in Madagascar: Facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrob Agents Chemother. 2009;53:4588-97.
61. Karema C, Imwong M, Fanello CI, Stepniewska K, Uwimana A, Nakeesathit S, et al. Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria. Antimicrob Agents Chemother. 2010;54:477-83.
62. Suleimanov SD. Drug-resistant tropical malaria in Angola. Med Parazitol (Mosk). 1994;2(2):8-10.
63. Gama BE, Pereira-Carvalho GA, Lutucuta Kosi FJ, Almeida de Oliveira NK, Fortes F, Rosenthal PJ, et al. Molecular markers of antifolate resistance in Plasmodium falciparum isolates from Luanda, Angola. Malar J. 2011;10:248.
64. Fortes F, Dimbu R, Figueiredo P, Neto Z, do VE, Rosario D. Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola. Malar J. 2011;10(10):22.
65. Kaingona EPS. Characterization of genes associated with chemoresistance pfdhps to sulfadoxine/pyrimethamine in isolates of Plasmodium falciparum in Lubango. Angola: Instituto Oswaldo Cruz; 2012.
66. Cairns M, Roca-Feltrer A, Garske T, Wilson AL, Diallo D, Milligan PJ, et al. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun. 2012;3:881.
67. Some AF, Zongo I, Compaore YD, Sakande S, Nosten F, Ouedraogo JB, et al. Selection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina Faso. Antimicrob Agents Chemother. 2014;58:3660-5.
68. Fivelman QL, Butcher GA, Adagu IS, Warhurst DC, Pasvol G. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos. Nigeria. Malar J. 2002;1:1.
69. Farnert A, Lindberg J, Gil P, Swedberg G, Berqvist Y, Thapar MM, et al. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: Case reports. BMJ. 2003;326:628-9.
70. Pimentel S, Nogueira F, Benchimol C, Quinhentos V, Bom J, Varandas L, et al. Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola. Malar J. 2006;5(5):30.
71. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, et al. Resistance of Plasmodium falciparum field isolates to in vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet. 2005;366:1960-3.
72. Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga C, et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 2015;47:226-34.
73. Escobar C, Pateira S, Lobo E, Lobo L, Teodosio R, Dias F, et al. Polymorphisms in Plasmodium falciparum K13-propeller in Angola and Mozambique after the introduction of the ACTs. PLoS One. 2015;10(3):e0119215.